📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice. (2019)

First Author: Broset E
Attributed to:  Definition and induction of broadly protective responses against HIV-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2019.01.014

PubMed Identifier: 30859110

Publication URI: http://europepmc.org/abstract/MED/30859110

Type: Journal Article/Review

Volume: 13

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501